MX2022013634A - Inhibidores de histona deacetilasa para inmunomodulacion en microambiente tumoral. - Google Patents
Inhibidores de histona deacetilasa para inmunomodulacion en microambiente tumoral.Info
- Publication number
- MX2022013634A MX2022013634A MX2022013634A MX2022013634A MX2022013634A MX 2022013634 A MX2022013634 A MX 2022013634A MX 2022013634 A MX2022013634 A MX 2022013634A MX 2022013634 A MX2022013634 A MX 2022013634A MX 2022013634 A MX2022013634 A MX 2022013634A
- Authority
- MX
- Mexico
- Prior art keywords
- immunomodulation
- tumor microenvironment
- histone deacetylase
- deacetylase inhibitors
- tumor
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 239000003276 histone deacetylase inhibitor Substances 0.000 title abstract 2
- 230000002519 immonomodulatory effect Effects 0.000 title abstract 2
- 229940121372 histone deacetylase inhibitor Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000001973 epigenetic effect Effects 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
- 230000004614 tumor growth Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente divulgación por lo general se refiere a compuestos de inhibidores de HDAC de clase I su producción y aplicaciones. Los compuestos poseen actividades inmunomoduladoras epigenéticas en el microambiente tumoral (TME) y, en consecuencia, inhibe el crecimiento de células tumorales.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063018427P | 2020-04-30 | 2020-04-30 | |
PCT/CN2021/090718 WO2021219040A1 (en) | 2020-04-30 | 2021-04-28 | Histone deacetylase inhibitors for immunomodulation in tumor microenvironment |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022013634A true MX2022013634A (es) | 2022-11-16 |
Family
ID=78373345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022013634A MX2022013634A (es) | 2020-04-30 | 2021-04-28 | Inhibidores de histona deacetilasa para inmunomodulacion en microambiente tumoral. |
Country Status (13)
Country | Link |
---|---|
US (2) | US11672788B2 (es) |
EP (1) | EP4142733A4 (es) |
JP (1) | JP2023524230A (es) |
KR (1) | KR20230005939A (es) |
CN (1) | CN116033904A (es) |
AU (1) | AU2021265994B2 (es) |
BR (1) | BR112022022015A2 (es) |
CA (1) | CA3176748A1 (es) |
IL (1) | IL297687A (es) |
MX (1) | MX2022013634A (es) |
TW (1) | TW202200557A (es) |
WO (1) | WO2021219040A1 (es) |
ZA (1) | ZA202212650B (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115322171B (zh) * | 2022-08-30 | 2023-03-17 | 深圳微芯生物科技股份有限公司 | 一种trka(g667c)和flt3靶点抑制剂及其与西达本胺的组合物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6174905B1 (en) | 1996-09-30 | 2001-01-16 | Mitsui Chemicals, Inc. | Cell differentiation inducer |
WO2004058234A2 (en) | 2002-12-27 | 2004-07-15 | Schering Aktiengesellschaft | Pharmaceutical combinations of phthalazine vegf inhibitors and benzamide hdac inhibitors |
ES2562778T3 (es) | 2003-12-02 | 2016-03-08 | The Ohio State University Research Foundation | Ácidos grasos de cadena corta unidos a motivos quelantes de Zn2+ como una clase novedosa de inhibidores de histona deacetilasa |
EP2205563A4 (en) | 2007-10-10 | 2012-01-25 | Orchid Res Lab Ltd | NEW HISTONDEACETYLASE INHIBITORS |
CN106916101B (zh) | 2017-02-15 | 2020-05-01 | 聚缘(上海)生物科技有限公司 | Nampt/hdac双靶点抑制剂及其制备方法 |
-
2021
- 2021-04-28 AU AU2021265994A patent/AU2021265994B2/en active Active
- 2021-04-28 JP JP2022565835A patent/JP2023524230A/ja active Pending
- 2021-04-28 US US17/243,378 patent/US11672788B2/en active Active
- 2021-04-28 CN CN202180031935.4A patent/CN116033904A/zh active Pending
- 2021-04-28 CA CA3176748A patent/CA3176748A1/en active Pending
- 2021-04-28 EP EP21796395.8A patent/EP4142733A4/en active Pending
- 2021-04-28 WO PCT/CN2021/090718 patent/WO2021219040A1/en active Application Filing
- 2021-04-28 IL IL297687A patent/IL297687A/en unknown
- 2021-04-28 MX MX2022013634A patent/MX2022013634A/es unknown
- 2021-04-28 BR BR112022022015A patent/BR112022022015A2/pt unknown
- 2021-04-28 KR KR1020227042007A patent/KR20230005939A/ko unknown
- 2021-04-28 TW TW110115446A patent/TW202200557A/zh unknown
-
2022
- 2022-11-21 ZA ZA2022/12650A patent/ZA202212650B/en unknown
-
2023
- 2023-05-01 US US18/310,387 patent/US20230263790A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20230263790A1 (en) | 2023-08-24 |
ZA202212650B (en) | 2024-04-24 |
JP2023524230A (ja) | 2023-06-09 |
US20210379032A1 (en) | 2021-12-09 |
IL297687A (en) | 2022-12-01 |
WO2021219040A1 (en) | 2021-11-04 |
EP4142733A1 (en) | 2023-03-08 |
KR20230005939A (ko) | 2023-01-10 |
AU2021265994B2 (en) | 2024-02-29 |
BR112022022015A2 (pt) | 2022-12-13 |
TW202200557A (zh) | 2022-01-01 |
EP4142733A4 (en) | 2023-03-08 |
US11672788B2 (en) | 2023-06-13 |
CN116033904A (zh) | 2023-04-28 |
AU2021265994A1 (en) | 2022-12-15 |
CA3176748A1 (en) | 2021-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202212650B (en) | Histone deacetylase inhibitors for immunomodulation in tumor microenvironment | |
MX2019012680A (es) | Metodos para complementar dietas con alto consumo de granos y/o alto valor energetico en rumiantes, mediante la administracion de un bioensamble sintetico de microbios, o cepas purificadas de los mismos. | |
MX2020009870A (es) | Inhibidores de histona desacetilasa. | |
DE602007011051D1 (de) | Lösungsmitteltolerante mikroorganismen und isolationsverfahren | |
MY191138A (en) | Multimodal polyethylene composition and a film comprising the same | |
MY196897A (en) | Microorganisms and methods for the biological production of ethylene glycol | |
HK1125359A1 (en) | N-sulphonylpyrroles and their use as histone deacetylase inhibitors n- | |
EA201792255A1 (ru) | Ингибиторы деацетилаз гистонов и композиции и способы их применения | |
EA200701969A1 (ru) | N-ГИДРОКСИАМИДЫ, ω-ЗАМЕЩЕННЫЕ ТРИЦИКЛИЧЕСКИМИ ГРУППАМИ, КАК ИНГИБИТОРЫ ГИСТОНДЕАЦЕТИЛАЗЫ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В ФАРМАЦЕВТИЧЕСКИХ ФОРМАХ | |
TW200708147A (en) | Multiple paging channels for efficient region paging | |
WO2019232025A3 (en) | Microbial engineering for the production of isoprenoids | |
MX2022014007A (es) | Compuestos como inhibidores de bcl-2. | |
MY190473A (en) | Multimodal polyethylene film | |
MX2021010321A (es) | Compuestos macrociclicos. | |
WO2017120204A3 (en) | Combination of histone deacetylase inhibitor and immunotherapy | |
EA200970284A1 (ru) | Ингибиторы гистоновых дезацетилаз с сочетанной активностью в отношении гистоновых дезацетилаз класса i и класса ii в комбинации с ингибиторами протеасом | |
MD3570834T2 (ro) | Inhibitori biciclici ai histon deacetilazei | |
MX2019007346A (es) | Inhibidores de histona deacetilasa. | |
MX2017014300A (es) | Inhibidores de histona deacetilasa y composiciones y metodos para el uso de los mismos. | |
PH12019501767A1 (en) | Methods and micro organisms for making 2,3-butanediol and derivatives thereof from ci carbons | |
PH12015500069A1 (en) | Histone deacetylase inhibitors and compositions and methods of use thereof | |
MX2020001484A (es) | Inhibidores bicíclicos de la histona desacetilasa. | |
NZ711585A (en) | Hdac inhibitors | |
CO2021016916A2 (es) | Métodos y composiciones para la fermentación bacteriana anaerobia | |
WO2018157749A8 (zh) | 一种利福霉素-喹嗪酮双靶标分子的新用途 |